TMO Form 4: Director Dion Weisler Receives Phantom Stock Units at $464.24
Rhea-AI Filing Summary
Dion J. Weisler, a director of Thermo Fisher Scientific, reported a Section 16 transaction dated 09/27/2025. The filing shows Phantom Stock Units were acquired under the company's Deferred Compensation Plan for Directors and are convertible 1-for-1 into common stock. The report states units were credited at $464.24 per unit and lists 80.78 as the number associated with the reported acquisition and 2,573.95 as the amount of common stock beneficially owned following the transaction. The units are distributable as stock upon cessation of director service or a change of control. The form was signed by an attorney-in-fact on 09/30/2025.
Positive
- Units are convertible 1-for-1 into common stock, providing straightforward equity linkage
- Transaction was executed under the Deferred Compensation Plan, showing standard director compensation governance and disclosure
Negative
- None.
Insights
TL;DR: Routine director deferred-compensation credit; convertible units increase deferred equity exposure but are non-cash until distribution.
The Form 4 documents a standard crediting of phantom stock units under the issuer's Director Deferred Compensation Plan, recorded at a closing price basis of $464.24 per unit. The instrument is convertible 1-for-1 into common shares and is distributable only upon service termination or change of control, so the transaction represents deferred equity compensation rather than an immediate equity sale or purchase. This is a typical Section 16 disclosure for directors and does not reflect open-market trading activity.
TL;DR: Disclosure aligns with standard director compensation practices; materiality to investors is low absent other changes.
The filing specifies that director retainers are deferred quarterly into stock units and credited as of the quarter end. The units’ 1-for-1 convertibility and distribution triggers (cessation of service or change of control) are explicitly stated, indicating standard vesting/distribution mechanics. The transaction increases disclosed beneficial ownership to 2,573.95 shares but reflects plan mechanics rather than a strategic ownership shift.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock Units | 80.78 | $0.00 | -- |
Footnotes (1)
- Convertible into Common Stock on a 1-for-1 basis. Represents stock units credited to the Reporting Person's account as of September 27, 2025, at a price of $464.24 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.